title: Aggregating and disaggregating patients in clinical trials and their subgroup analyses.
authors.forename: David M
authors.initials: DM
authors.lastname: Kent
authors.forename: Peter K
authors.initials: PK
authors.lastname: Lindenauer
mesh_terms: D000208:Acute Disease; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D003627:Data Interpretation, Statistical; D003692:Delayed-Action Preparations; D017984:Enoxaparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D051346:Mobility Limitation; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D018570:Risk Assessment; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D003692:Delayed-Action Preparations; D017984:Enoxaparin